These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30716792)

  • 21. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.
    Avery-Kiejda KA; Braye SG; Mathe A; Forbes JF; Scott RJ
    BMC Cancer; 2014 Jan; 14():51. PubMed ID: 24479446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases.
    Fang Z; Wang R; Yang C; Wang D; Chen W; Lin B; Gong D; Li S; Liang J; Liang X; Zeng C; Li J; Wang K; Lv W
    Dis Markers; 2021; 2021():7879508. PubMed ID: 34853623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
    Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
    Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases.
    Escuin D; López-Vilaró L; Mora J; Bell O; Moral A; Pérez I; Arqueros C; García-Valdecasas B; Ramón Y Cajal T; Lerma E; Barnadas A
    Front Oncol; 2021; 11():627811. PubMed ID: 34513655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
    Dong LF; Xu SY; Long JP; Wan F; Chen YD
    J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
    Qiao EQ; Yang HJ; Zhang XP
    J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer.
    Shiino S; Matsuzaki J; Shimomura A; Kawauchi J; Takizawa S; Sakamoto H; Aoki Y; Yoshida M; Tamura K; Kato K; Kinoshita T; Kitagawa Y; Ochiya T
    Clin Cancer Res; 2019 Mar; 25(6):1817-1827. PubMed ID: 30482779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [microRNA expression in breast development and breast cancer].
    Avril S
    Pathologe; 2013 Nov; 34 Suppl 2():195-200. PubMed ID: 24196612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort.
    Dihge L; Vallon-Christersson J; Hegardt C; Saal LH; Häkkinen J; Larsson C; Ehinger A; Loman N; Malmberg M; Bendahl PO; Borg Å; Staaf J; Rydén L
    Clin Cancer Res; 2019 Nov; 25(21):6368-6381. PubMed ID: 31340938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
    Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node.
    Zhou Y; Huang X; Mao F; Lin Y; Shen S; Guan J; Zhang X; Sun Q
    Medicine (Baltimore); 2019 Jan; 98(1):e13916. PubMed ID: 30608418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
    Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
    Akay CL; Albarracin C; Torstenson T; Bassett R; Mittendorf EA; Yi M; Kuerer HM; Babiera GV; Bedrosian I; Hunt KK; Hwang RF
    Breast J; 2018 Jan; 24(1):28-34. PubMed ID: 28608612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing
    Sarikaya I; Sarikaya A
    J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.